CytomX Therapeutics
CTMX
#9040
Rank
โ‚ฌ82.02 M
Marketcap
1,05ย โ‚ฌ
Share price
0.00%
Change (1 day)
-21.92%
Change (1 year)

Revenue for CytomX Therapeutics (CTMX)

Revenue in 2024 (TTM): โ‚ฌ0.11 Billion

According to CytomX Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. In 2023 the company made a revenue of โ‚ฌ91.55 Million an increase over the revenue in the year 2022 that were of โ‚ฌ31.68 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for CytomX Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚ฌ0.11 B26.5%
2023 โ‚ฌ91.55 M188.98%
2022 โ‚ฌ31.68 M-48.43%
2021 โ‚ฌ61.43 M-24.71%
2020 โ‚ฌ81.59 M59%
2019 โ‚ฌ51.31 M-1.33%
2018 โ‚ฌ52.01 M-12.87%
2017 โ‚ฌ59.69 M317.39%
2016 โ‚ฌ14.3 M102.76%
2015 โ‚ฌ7.05 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA